Nathaniel Magilnick Selected Research

Nathaniel Magilnick Research Topics

2	Inflammation (Inflammations) 01/2021 - 01/2016
1	Neuroinflammatory Diseases 01/2022
1	Infections 01/2021
1	Bone Marrow Failure Disorders 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Splenomegaly 01/2017
1	Atherosclerosis 11/2016
1	Proteinuria 01/2016
1	Hypertrophy 01/2016
1	Fibrosis (Cirrhosis) 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 01/2008
1	Liver Neoplasms (Liver Cancer) 03/2007
1	Necrosis 10/2005

2	InterferonsIBA 01/2021 - 11/2016
1	LipopolysaccharidesIBA 01/2022
1	Green Fluorescent ProteinsIBA 01/2021
1	ChemokinesIBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	Cell-Penetrating PeptidesIBA 01/2021
1	CytokinesIBA 01/2017
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2017
1	PlasticsIBA 11/2016
1	Apolipoproteins E (ApoE)IBA 11/2016
1	Streptozocin (Streptozotocin)FDA Link 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	InflammasomesIBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2008
1	Messenger RNA (mRNA)IBA 01/2008
1	Methionine AdenosyltransferaseIBA 01/2008
1	MitogensIBA 03/2007
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2007
1	NF-kappa B (NF-kB)IBA 10/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2005
1	EnzymesIBA 10/2005
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 10/2005

1	Intranasal Administration 01/2021